International Journal of Radiation Oncology * Biology * Physics
Volume 49, Issue 4 , Pages 973-985 , 15 March 2001

Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach

Preliminary results of this work were presented at the Annual Meetings of the Canadian Association of Radiation Oncologists, in 1998 and 1999.

  • Scott Tyldesley, M.D. (F.R.C.P.C.)

      Affiliations

    • Radiation Oncology Research Unit, Queen’s University, Kingston, Ontario, Canada
    • Departments of Oncology, and Community Health and Epidemiology, Queen’s University, Kingston, Ontario, Canada
    • Kingston Regional Cancer Centre, Kingston, Ontario, Canada
    • Kingston General Hospital, Kingston, Ontario, Canada
    • Dr. Tyldesley was a Health Policy Research Fellow at the Radiation Oncology Research Unit at Queen’s University. He is now a Staff Radiation Oncologist at the Vancouver Cancer Clinic.
  • ,
  • Chris Boyd (M.Sc.)

      Affiliations

    • Radiation Oncology Research Unit, Queen’s University, Kingston, Ontario, Canada
    • Departments of Oncology, and Community Health and Epidemiology, Queen’s University, Kingston, Ontario, Canada
  • ,
  • Karleen Schulze (M.Math.)

      Affiliations

    • Radiation Oncology Research Unit, Queen’s University, Kingston, Ontario, Canada
    • Departments of Oncology, and Community Health and Epidemiology, Queen’s University, Kingston, Ontario, Canada
  • ,
  • Hugh Walker, Ph.D.

      Affiliations

    • Radiation Oncology Research Unit, Queen’s University, Kingston, Ontario, Canada
    • Departments of Oncology, and Community Health and Epidemiology, Queen’s University, Kingston, Ontario, Canada
  • ,
  • William J Mackillop (M.B., Ch.B., F.R.C.P.C.)

      Affiliations

    • Radiation Oncology Research Unit, Queen’s University, Kingston, Ontario, Canada
    • Departments of Oncology, and Community Health and Epidemiology, Queen’s University, Kingston, Ontario, Canada
    • Kingston Regional Cancer Centre, Kingston, Ontario, Canada
    • Kingston General Hospital, Kingston, Ontario, Canada
    • Corresponding Author InformationReprint requests to: Dr. W. J. Mackillop, Kingston General Hospital, Radiation Oncology Research Unit, Apps Level 4, 76 Stuart Street Kingston, Ontario, Canada K7L, 2V7

,Accepted 22 August 2000.

References 

  1. Intersociety-Council for Radiation Oncology. Radiation Oncology in integrated cancer management. Report to the Director of the National Cancer Institute, Washington, DC: 1991.
  2. Ontario Cancer Treatment, and Research Foundation. A plan for radiation treatment, province of Ontario, 1995–2000. Toronto, Ontario: OCTRF; 1995.
  3. Duncan W, Jenkin D. The Radiation Oncology Commission: A Report to the Ontario Treatment and Research Foundation, and the Ontario Cancer Institute. Toronto, Canada: OCTRF; 1990.
  4. The Committee for Radiation Oncology Studies. Criteria for Radiation Oncology in multidisciplinary cancer management. Report to the Director of the National Cancer Institute, Washington, DC: 1981.
  5. Frodin JE, Jonsson E, Moller T, et al.  Radiotherapy in Sweden. A study of present use in relation to the literature and an estimate of future trends. Acta Oncol. 1996;35(8):967–979
  6. Cleton FJ, Coebergh JWW, (ed for Steering Committee on Future Health Scenarios). Cancer in the Netherlands. Dordrecht, the Netherlands: Kluwer Academic; 1991.
  7. Mackillop WJ, Groome PA, Zhang-Salomoms J, et al.  Does a centralized radiotherapy system provide adequate access to care?. J Clin Oncol. 1997;15(3):1261–1271
  8. Mackillop WJ, Dixon P, Zhou Y, et al.  Variations in the management and outcome of non-small cell lung cancer in Ontario. Radiother Oncol. 1994;32:105–115
  9. Denham JW. How do we bring an acceptable level of radiotherapy services to a dispersed population?. Australas Radiol. 1995;39:171–173
  10. Lote K, Moller T, Nordman E, et al.  Resources of productivity in radiation oncology in Denmark, Finland, Iceland, Norway and Sweden during 1987. Acta Oncol. 1991;30:555–561
  11. Wright J. Health needs assessment in practice. London, UK: BMJ Publishing Group; 1998;
  12. Sanderson C, Hunter D, McKee M, et al.  Limitations of epidemiologically based needs assessment (The case of prostatectomy). Med Care. 1997;35(7):669–685
  13. American Heritage Dictionary of the English Language. 3rd ed. Boston: Houghton Mifflin; 1996.
  14. American Society of Clinical Oncology . Clinical practice guidelines for the treatment of unresectable non-small cell lung cancer. J Clin Oncol. 1997;15(8):2996–3018
  15. Ettinger DS, Cox JD, Ginsburg RJ, et al.  NCCN non-small-cell lung cancer practice guidelines. Oncology. 1996;10(Suppl. 11):81–111
  16. Demetri G, Elias A, Gerhenson D, et al.  NCCN small-cell lung cancer practice guidelines. Oncology. 1996;10(Suppl. 11):179–194
  17. American College of Radiology Task Force on Appropriateness Criteria . Appropriateness criteria for imaging and treatment decisions in radiation oncology. Reston, VA: American College of Radiology; 1996;
  18. National Cancer Institute. CancerNet. A service of the National Cancer Institute: PDQ Cancer Information Summaries: Treatment. Monograph on line. Accessed Dec/99. (url: http://cancernet.nci.nih.gov/pdq/pdq_treatment.shtml).
  19. British Columbia Cancer Agency. Cancer Management Manual. Monograph on line. Accessed Dec/99. (url: http://www. bccancer.bc.ca/cmm/lung/).
  20. Cancer Care Ontario Practice Guidelines Initiative. Lung Cancer Clinical Practice Guidelines. Monograph on line. Accessed Dec/99. (url: http://hiru.mcmaster.ca/ccopgi/lungcpg.html).
  21. Royal College of Radiologists’ Clinical Oncology Information Network . Guidelines on the non-surgical management of lung cancer. Clin Oncol. 1999;11:S1–S51
  22. Scottish Intercollegiate Guidelines Network. Management of Lung Cancer. Monograph on line. Accessed Mar/00. (url: http://www. Show.scot.nhs.uk/sign/html/htmltxt23.htm).
  23. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest. 1989;95(Suppl. 2):2S–4S
  24. Eddy DM. A manual for assessing health practices and designing practice policies. Philadelphia, PA: American College of Physicians; 1992;
  25. Nattinger AB, McAuliffe TL, Schapira MM. Generalizability of the surveillance, epidemiology, and end results registry population (Factors relevant to epidemiologic and health care research). J Clin Epidemiol. 1997;50:939–945
  26. Clarke EA, Marrett LD, Kreiger N. Cancer registration in Ontario: A computer approach. In: Jensen OM, Parkin DM, Maclennan R; et al., editors. Cancer registration principles and methods. Lyon, France: International Agency for Research on Cancer; 1991. p. 246–257.
  27. Fry WA, Menck HR, Winchester DP. The national cancer data base report. Cancer. 1996;77:1947–1955
  28. Bishop YMM, Fienberg SE, Holland PW. Discrete multivariate analysis. Theory and practice. Cambridge, MA: The MIT Press; 1975;
  29. Brown JS, Eraut D, Trask C, et al.  Age and the treatment of lung cancer. Thorax. 1996;51:564–568
  30. Ruckedeschel JC, Finkelstein DM, Ettinger DS, et al.  A randomized trial of the four most active regimens for metastatic non-small cell cancer. J Clin Oncol. 1986;4:14–22
  31. Rapp E, Pater JLP, Willan A, et al.  Chemotherapy can prolong survival in patients with advanced non-small cell lung cancer—Report of a Canadian multicenter randomized trial. J Clin Oncol. 1988;6(4):633–641
  32. Carrol M, Morgan SA, Yarnold JR, et al.  Prospective evaluation of a watch policy inpatients with inoperable non-small cell lung cancer. Eur J Clin Oncol. 1986;22(11):1353–1356
  33. Culyer AH. Need and the National Health Service (Economics and social choice). New Jersey: Rowman and Littlefield; 1976;
  34. Eyles J, Birch S, Chambers S, et al.  A needs-based methodology for allocating health care resources in Ontario, Canada (Development and an application). Soc Sci Med. 1991;33(4):489–500
  35. Murray N, Coy P, Pater JL, et al.  Importance of timing of thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol. 1993;11(2):336–344
  36. Abrams J, Doyle LA, Aisner J, et al.  Staging, prognostic factors, and special considerations in small cell lung cancer. Semin Oncol. 1988;15(3):261–277
  37. Ettinger D, Finkelstein D, Abeloff M, et al.  A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance for extensive-stage small-cell lung cancer (A phase III study of the eastern cooperative oncology group). J Clin Oncol. 1990;8(2):230–240
  38. Gatzemeier U, Pawel J, Laumen R, et al.  Etoposide/vincristine-based chemotherapy with of without carboplatin in extensive-stage small cell lung cancer. A prospective randomized phase III trial. Semin Oncol. 1994;21(3):31–35
  39. Evans WK, Feld MD, Murray N, et al.  Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. Ann Intern Med. 1987;107(4):451–458
  40. Roth BJ, Johnson DH, Einhorn LH, et al.  Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small cell lung cancer (A phase III trial of the Southeastern Cancer Study Group). J Clin Oncol. 1992;10(2):282–291
  41. Kaiser L, Fleshner P, Keller S, et al.  Significance of extramucosal residual tumor at the bronchial resection margin. Ann Thorac Surg. 1989;47:265–269
  42. Dienemann H, Trainer C, Hoffmann H, et al.  Incomplete resections in bronchial carcinoma (Morbidity and prognosis (German)). Chirurg. 1997;68(10):1014–1019
  43. Jeffery R. Survival in bronchial carcinoma. Ann Roy Coll Surg Engl. 1972;51:55–58
  44. Harpole D, Healey E, DeCamp M, et al.  Chest wall invasive non-small cell lung cancer (Patterns of failure and implications for a revised staging system). Ann Surg Oncol. 1996;3(3):261–269
  45. Rusch V, Albain K, Crowley J, et al.  Neoadjuvant therapy. A novel and effective treatment for stage IIIb non-small cell lung cancer. Ann Thorac Surg. 1994;58:290–295
  46. Brundage MD, Davidson JR, Mackillop WJ. Trading treatment toxicity for survival in locally advanced non-small cell lung cancer. J Clin Oncol. 1997;15(1):330–340
  47. Osterlind K, Hansen HH, Hansen HS, et al.  Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up. Br J Cancer. 1986;54:7–17
  48. Souhami RL, Geddes DM, Spiro SG, et al.  Radiotherapy in small cell cancer of the lung treated with combination chemotherapy (A controlled trial). BMJ. 1984;288:1643–1648
  49. Ihde DC, Mulshine JL, Barnett S, et al.  Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J Clin Oncol. 1994;12(10):2022–2024
  50. Chahinian AP, Propert KJ, Ware JH, et al.  A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B. J Clin Oncol. 1989;7(8):993–1002
  51. Van Houtte P, Rocmas P, Smets P, et al.  Postoperative radiation therapy in lung cancer (A controlled trial after resection of curative design). Int J Radiat Oncol Biol Phys. 1980;6:983–986
  52. Medical Research Council Lung Cancer Working Party . The role of post-operative radiotherapy in non-small cell lung cancer (A multicentre randomized trial in patients with pathologically staged T1–2, N1–2, M0 disease). Br J Cancer. 1996;74(4):632–639
  53. Lung Cancer Study Group . Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med. 1986;315:1377–1381

 Supported in part by grants from the National Cancer Institute of Canada, with funding from the Canadian Cancer Society and Cancer Care Ontario (W.J.M.). Fellowship support for S. Tyldesley was provided by the Terry Fox Fellowship Fund of the National Cancer Institute of Canada, and the Shane Fellowship from the Order of the Eastern Star.

PII: S0360-3016(00)01401-2

doi: 10.1016/S0360-3016(00)01401-2

International Journal of Radiation Oncology * Biology * Physics
Volume 49, Issue 4 , Pages 973-985 , 15 March 2001